Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Yeast Sir2p (Silent Information Regulator 2) is the founding member of the sirtuin family of NAD+-dependent protein deacetylases (UniProt [1]). It is primarily known for its role in gene silencing at the silent mating-type loci, telomeres, and ribosomal DNA (rDNA) in Saccharomyces cerevisiae (PMC [6]). By deacetylating lysine residues on histones, particularly H4K16, Sir2p promotes the formation of repressive heterochromatin and suppresses unequal recombination within the rDNA repeats (PMC [7]). This suppression of recombination is a major factor in determining the replicative lifespan of yeast cells, as it prevents the formation of toxic extrachromosomal rDNA circles (PubMed [12]). Sir2p also acts as a metabolic sensor, linking the availability of NAD+ to the regulation of aging and stress responses, particularly during calorie restriction (PMC [14]). In addition to its role in yeast biology, Sir2p serves as a critical model for understanding human sirtuins like SIRT1, which are implicated in age-related diseases and cancer (PMC [13]). Small molecules such as resveratrol have been identified as activators of Sir2p, while compounds like splitomicin and nicotinamide act as potent inhibitors (PMC [8], PMC [9]). Research into Sir2p continues to provide insights into the epigenetic mechanisms of longevity and the potential for therapeutic intervention in metabolic and degenerative disorders (NCBI [10]).
NAD+-dependent deacetylation of lysine residues on histones and other proteins, coupled with the hydrolysis of NAD+ to produce nicotinamide and O-acetyl-ADP-ribose (UniProt [1], PMC [7]).
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on NAD-dependent histone deacetylase SIR2 (Sir2p) (Sir2p).